Recently, HLA-B*15:02 screening has been preliminarily introduced by the National Health Security Office (NHSO), Thailand, to screen patients who may be at risk of carbamazepine-induced SJS/TEN. This evidence concerns the gene HLA-B and Schwartz-Jampel syndrome.